Skip to main content
Erschienen in: Archives of Women's Mental Health 2/2017

21.12.2016 | Original Article

Depression during the menopause transition: impact on quality of life, social adjustment, and disability

verfasst von: Bathsheba A. Wariso, Gioia M. Guerrieri, Karla Thompson, Deloris E. Koziol, Nazli Haq, Pedro E. Martinez, David R. Rubinow, Peter J. Schmidt

Erschienen in: Archives of Women's Mental Health | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The impact of depression on quality of life (QOL) and social support has neither been well characterized in clinical samples of women with perimenopausal depression (PMD) nor have the relative contributions of depression and other menopausal symptoms (e.g., hot flushes) to declining QOL been clarified. In this study, we compared QOL measures, social support, and functional disability in PMD and non-depressed perimenopausal women. We evaluated women aged 40–60 years who presented with menstrual cycle irregularity, elevated plasma FSH levels, and met criteria for perimenopause. A structured clinical interview was administered to determine the presence or absence of major and minor depression. Outcome measures included the Quality of Life Enjoyment Scale Questionnaire, the Sheehan Disability Scale, the Global Assessment of Functioning, the Social Adjustment Scale, and the Duke Social Support Index. Kruskal-Wallis tests and ANOVAs were used to compare outcome measures. Ninety women with PMD and 51 control women participated in this study. Women with PMD reported significantly decreased QOL, social support, and adjustment and increased disability compared with non-depressed perimenopausal women. Neither perimenopausal reproductive status alone nor the presence of hot flushes had a significant negative impact on QOL measures. PMD is accompanied by significant reductions in QOL, social support, and disability similar to depression in women at other stages of life. PMD may also contribute to decreased QOL in community- or clinic-based samples of perimenopausal women. It remains unclear whether the clinical characteristics we identified reflect pre-existing risk factors for depression during the perimenopause or the effects of a current depression. Future clinical and treatment studies in perimenopausal women should distinguish depressed women when outcome measures include QOL.
Literatur
Zurück zum Zitat Archer DF, Sturdee DW, Baber R, de Villiers TJ, Pines A, Freedman RR, Gompel A, Hickey M, Hunter MS, Lobo RA, Lumsden MA, MacLennan AH, Maki P, Palacios S, Shah D, Villaseca P, Warren M (2011) Menopausal hot flushes and night sweats: where are we now? Climacteric 14:515–528CrossRefPubMed Archer DF, Sturdee DW, Baber R, de Villiers TJ, Pines A, Freedman RR, Gompel A, Hickey M, Hunter MS, Lobo RA, Lumsden MA, MacLennan AH, Maki P, Palacios S, Shah D, Villaseca P, Warren M (2011) Menopausal hot flushes and night sweats: where are we now? Climacteric 14:515–528CrossRefPubMed
Zurück zum Zitat Bothwell S, Weissman MM (1977) Social impairments four years after an acute depressive episode. Am J Orthopsychiatry 47:231–237CrossRefPubMed Bothwell S, Weissman MM (1977) Social impairments four years after an acute depressive episode. Am J Orthopsychiatry 47:231–237CrossRefPubMed
Zurück zum Zitat Bromberger JT, Matthews KA, Schott LL, Brockwell S, Avis NE, Kravitz HM, Everson-Rose SA, Gold EB, Sowers M, Randolph JF Jr (2007) Depressive symptoms during the menopausal transition: the study of women’s health across the nation (SWAN). J Affective Disord 103:267–272CrossRef Bromberger JT, Matthews KA, Schott LL, Brockwell S, Avis NE, Kravitz HM, Everson-Rose SA, Gold EB, Sowers M, Randolph JF Jr (2007) Depressive symptoms during the menopausal transition: the study of women’s health across the nation (SWAN). J Affective Disord 103:267–272CrossRef
Zurück zum Zitat Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL (2006) Risk for new onset of depression during the menopausal transition. The Harvard study of moods and cycles. Arch Gen Psychiatry 63:385–390CrossRefPubMed Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL (2006) Risk for new onset of depression during the menopausal transition. The Harvard study of moods and cycles. Arch Gen Psychiatry 63:385–390CrossRefPubMed
Zurück zum Zitat Endicott J, Harrison W (1990) Daily rating of severity of problems form. New York State Psychiatric Institute, Department of Research Assessment and Training, New York Endicott J, Harrison W (1990) Daily rating of severity of problems form. New York State Psychiatric Institute, Department of Research Assessment and Training, New York
Zurück zum Zitat Endicott J, Lam RW, Hsu MA, Fayyad R, Boucher M, Guico-Pabia CJ (2014) Improvements in quality of life with desvenlafaxine 50 mg/d vs placebo in employed adults with major depressive disorder. J Affect Disord 166:307–314CrossRefPubMed Endicott J, Lam RW, Hsu MA, Fayyad R, Boucher M, Guico-Pabia CJ (2014) Improvements in quality of life with desvenlafaxine 50 mg/d vs placebo in employed adults with major depressive disorder. J Affect Disord 166:307–314CrossRefPubMed
Zurück zum Zitat Endicott J, Nee J, Cohen J, Halbreich U (1986) Premenstrual changes: patterns and correlates of daily ratings. J Affective Disord 10:127–135CrossRef Endicott J, Nee J, Cohen J, Halbreich U (1986) Premenstrual changes: patterns and correlates of daily ratings. J Affective Disord 10:127–135CrossRef
Zurück zum Zitat Endicott J, Nee J, Harrison W, Blumenthal R (1993) Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29:321–326PubMed Endicott J, Nee J, Harrison W, Blumenthal R (1993) Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29:321–326PubMed
Zurück zum Zitat First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-IP). Biometrics Research, New York State Psychiatric Institute, New York First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-IP). Biometrics Research, New York State Psychiatric Institute, New York
Zurück zum Zitat Freeman EW, Sammel MD, Boorman DW, Zhang R (2013) The longitudinal pattern of depressive symptoms around natural menopause. Freeman EW, Sammel MD, Boorman DW, Zhang R (2013) The longitudinal pattern of depressive symptoms around natural menopause.
Zurück zum Zitat Freeman EW, Sammel MD, Lin H, Nelson DB (2006) Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63:375–382CrossRefPubMed Freeman EW, Sammel MD, Lin H, Nelson DB (2006) Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63:375–382CrossRefPubMed
Zurück zum Zitat Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L (2004) Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61:62–70CrossRefPubMed Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L (2004) Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61:62–70CrossRefPubMed
Zurück zum Zitat Goodger B, Byles J, Higganbotham N, Mishra G (1999) Assessment of a short scale to measure social support among older people. Aust N Z J Public Health 23:260–265CrossRefPubMed Goodger B, Byles J, Higganbotham N, Mishra G (1999) Assessment of a short scale to measure social support among older people. Aust N Z J Public Health 23:260–265CrossRefPubMed
Zurück zum Zitat Grady D, Ettinger B, Tosteson ANA, Pressman A, Macer JL (2003) Predictors of difficulty when discontinuing postmenopausal hormone therapy. Obstet Gynecol 102:1233–1239PubMed Grady D, Ettinger B, Tosteson ANA, Pressman A, Macer JL (2003) Predictors of difficulty when discontinuing postmenopausal hormone therapy. Obstet Gynecol 102:1233–1239PubMed
Zurück zum Zitat Greden JF (2001) The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry 62(suppl 22):5–9PubMed Greden JF (2001) The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry 62(suppl 22):5–9PubMed
Zurück zum Zitat Grootenboer EM, Giltay EJ, van der Lem R, van VT, van der Wee NJ, Zitman FG (2012) Reliability and validity of the Global Assessment of Functioning Scale in clinical outpatients with depressive disorders. J Eval Clin Pract 18:502–507CrossRefPubMed Grootenboer EM, Giltay EJ, van der Lem R, van VT, van der Wee NJ, Zitman FG (2012) Reliability and validity of the Global Assessment of Functioning Scale in clinical outpatients with depressive disorders. J Eval Clin Pract 18:502–507CrossRefPubMed
Zurück zum Zitat Halbreich U, Kahn LS (2007) Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes? J Affective Disord 102:245–258CrossRef Halbreich U, Kahn LS (2007) Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes? J Affective Disord 102:245–258CrossRef
Zurück zum Zitat Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG (2003) Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 348:1839–1854CrossRefPubMed Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG (2003) Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 348:1839–1854CrossRefPubMed
Zurück zum Zitat Hays JC, Krishnan KR, George LK, Pieper CF, Flint EP, Blazer DG (1997) Psychosocial and physical correlates of chronic depression. Psychiatry Res 72:149–159CrossRefPubMed Hays JC, Krishnan KR, George LK, Pieper CF, Flint EP, Blazer DG (1997) Psychosocial and physical correlates of chronic depression. Psychiatry Res 72:149–159CrossRefPubMed
Zurück zum Zitat Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E (1996) A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 24:161–175CrossRefPubMed Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E (1996) A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 24:161–175CrossRefPubMed
Zurück zum Zitat Hilsenroth MJ, Ackerman SJ, Blagys MD, Baumann BD, Baity MR, Smith SR, Price JL, Smith CL, Heindselman TL, Mount MK, Holdwick DJ Jr (2000) Reliability and validity of DSM-IV axis V. Am J Psychiatry 157:1858–1863CrossRefPubMed Hilsenroth MJ, Ackerman SJ, Blagys MD, Baumann BD, Baity MR, Smith SR, Price JL, Smith CL, Heindselman TL, Mount MK, Holdwick DJ Jr (2000) Reliability and validity of DSM-IV axis V. Am J Psychiatry 157:1858–1863CrossRefPubMed
Zurück zum Zitat Hirschfeld RMA (2002) The mood disorder questionnaire: a simple, patient-rated screening instrument for bipolar disorder. Prim Care Companion J Clin Psychiatry 4:9–11CrossRefPubMedPubMedCentral Hirschfeld RMA (2002) The mood disorder questionnaire: a simple, patient-rated screening instrument for bipolar disorder. Prim Care Companion J Clin Psychiatry 4:9–11CrossRefPubMedPubMedCentral
Zurück zum Zitat Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA (2002) Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the heart and estrogen/progestin replacement study (HERS) trial. J A M A 5:591–597CrossRef Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA (2002) Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the heart and estrogen/progestin replacement study (HERS) trial. J A M A 5:591–597CrossRef
Zurück zum Zitat Ishak WW, Balayan K, Bresee C, Greenberg JM, Fakhry H, Christensen S, Rapaport MH (2013) A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Qual Life Res 22:585–596CrossRefPubMed Ishak WW, Balayan K, Bresee C, Greenberg JM, Fakhry H, Christensen S, Rapaport MH (2013) A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Qual Life Res 22:585–596CrossRefPubMed
Zurück zum Zitat Joffe H, Petrillo LF, Koukopoulos A, Viguera AC, Hirschberg A, Nonacs R, Somley B, Pasciullo E, White DP, Hall JE, Cohen LS (2011) Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J Clin Endocrinol Metab 96:E1044–E1954CrossRefPubMedPubMedCentral Joffe H, Petrillo LF, Koukopoulos A, Viguera AC, Hirschberg A, Nonacs R, Somley B, Pasciullo E, White DP, Hall JE, Cohen LS (2011) Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J Clin Endocrinol Metab 96:E1044–E1954CrossRefPubMedPubMedCentral
Zurück zum Zitat Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) The epidemiology of major depressive disorder. Results from the National Comorbidity Survey Replication (NCS-R). J A M A 289:3095–3105CrossRefPubMed Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) The epidemiology of major depressive disorder. Results from the National Comorbidity Survey Replication (NCS-R). J A M A 289:3095–3105CrossRefPubMed
Zurück zum Zitat Koenig HG, Westlund RE, George LK, Hughes DC, Blazer DG, Hybels C (1993) Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals. Psychosomatics 34:61–69CrossRefPubMed Koenig HG, Westlund RE, George LK, Hughes DC, Blazer DG, Hybels C (1993) Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals. Psychosomatics 34:61–69CrossRefPubMed
Zurück zum Zitat Kornstein SG, Clayton A, Bao W, Guico-Pabia CJ (2014) Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. Menopause 21:799–806CrossRefPubMed Kornstein SG, Clayton A, Bao W, Guico-Pabia CJ (2014) Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. Menopause 21:799–806CrossRefPubMed
Zurück zum Zitat Lai CH (2011) Major depressive disorder: gender differences in symptoms, life quality, and sexual function. J Clin Psychopharmacol 31:39–44CrossRefPubMed Lai CH (2011) Major depressive disorder: gender differences in symptoms, life quality, and sexual function. J Clin Psychopharmacol 31:39–44CrossRefPubMed
Zurück zum Zitat Landerman R, George LK, Campbell RT, Blazer DG (1989) Alternative models of the stress buffering hypothesis. Am J Community Psychol 17:625–642CrossRefPubMed Landerman R, George LK, Campbell RT, Blazer DG (1989) Alternative models of the stress buffering hypothesis. Am J Community Psychol 17:625–642CrossRefPubMed
Zurück zum Zitat Matthews KA, Bromberger JT (2005) Does the menopausal transition affect health-related quality of life? Am J Med 118:25S–36SCrossRef Matthews KA, Bromberger JT (2005) Does the menopausal transition affect health-related quality of life? Am J Med 118:25S–36SCrossRef
Zurück zum Zitat Ness J, Aronow WS, Beck G (2006) Menopausal symptoms after cessation of hormone replacement therapy. Maturitas 53:356–361CrossRefPubMed Ness J, Aronow WS, Beck G (2006) Menopausal symptoms after cessation of hormone replacement therapy. Maturitas 53:356–361CrossRefPubMed
Zurück zum Zitat Ockene JK, Barad DH, Cochrane BB, Larson JC, Gass M, Wassertheil-Smoller S, Manson JE, Barnabei VM, Lane DS, Brzyski RG, Rosal MC, Wylie-Rosett J, Hays J (2005) Symptom experience after discontinuing use of estrogen plus progestin. J A M A 294:183–193CrossRefPubMed Ockene JK, Barad DH, Cochrane BB, Larson JC, Gass M, Wassertheil-Smoller S, Manson JE, Barnabei VM, Lane DS, Brzyski RG, Rosal MC, Wylie-Rosett J, Hays J (2005) Symptom experience after discontinuing use of estrogen plus progestin. J A M A 294:183–193CrossRefPubMed
Zurück zum Zitat Ohayon MM (2006) Severe hot flashes are associated with chronic insomnia. Arch Intern Med 166:1262–1268CrossRefPubMed Ohayon MM (2006) Severe hot flashes are associated with chronic insomnia. Arch Intern Med 166:1262–1268CrossRefPubMed
Zurück zum Zitat Pachana NA, Smith N, Watson M, McLaughlin D, Dobson A (2008) Responsiveness of the Duke Social Support sub-scales in older women. Age Ageing 37:666–672CrossRefPubMed Pachana NA, Smith N, Watson M, McLaughlin D, Dobson A (2008) Responsiveness of the Duke Social Support sub-scales in older women. Age Ageing 37:666–672CrossRefPubMed
Zurück zum Zitat Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA (2000) Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry 61:101–109CrossRefPubMed Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA (2000) Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry 61:101–109CrossRefPubMed
Zurück zum Zitat Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R (2008) Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. J Psychiatr Res 42:1042–1049CrossRefPubMed Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R (2008) Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. J Psychiatr Res 42:1042–1049CrossRefPubMed
Zurück zum Zitat Rapaport MH, Clary C, Fayyad R, Endicott J (2005) Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 162:1171–1178CrossRefPubMed Rapaport MH, Clary C, Fayyad R, Endicott J (2005) Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 162:1171–1178CrossRefPubMed
Zurück zum Zitat Roberts RE, Vernon SW (1983) The center for epidemiologic studies depression scale: its use in a community sample. Am J Psychiatry 140:41–46CrossRefPubMed Roberts RE, Vernon SW (1983) The center for epidemiologic studies depression scale: its use in a community sample. Am J Psychiatry 140:41–46CrossRefPubMed
Zurück zum Zitat Rubinow DR, Johnson SL, Schmidt PJ, Girdler S, Gaynes B (2015) Efficacy of estradiol in perimenopausal depression: so much promise and so few answers. Depress Anxiety 32:539–549CrossRefPubMed Rubinow DR, Johnson SL, Schmidt PJ, Girdler S, Gaynes B (2015) Efficacy of estradiol in perimenopausal depression: so much promise and so few answers. Depress Anxiety 32:539–549CrossRefPubMed
Zurück zum Zitat Santen RJ et al (2010) Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 95(7 Suppl 1):s1–s66CrossRefPubMed Santen RJ et al (2010) Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 95(7 Suppl 1):s1–s66CrossRefPubMed
Zurück zum Zitat Schechter D, Endicott J, Nee J (2007) Quality of life of ‘normal’ controls: association with lifetime history of mental illness. Psychiatry Res 152:45–54CrossRefPubMedPubMedCentral Schechter D, Endicott J, Nee J (2007) Quality of life of ‘normal’ controls: association with lifetime history of mental illness. Psychiatry Res 152:45–54CrossRefPubMedPubMedCentral
Zurück zum Zitat Schmidt PJ, Ben Dor R, Martinez PE, Guerrieri GM, Harsh VL, Thompson K, Koziol DE, Nieman LK, Rubinow DR (2015) Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry 72:714–726CrossRefPubMed Schmidt PJ, Ben Dor R, Martinez PE, Guerrieri GM, Harsh VL, Thompson K, Koziol DE, Nieman LK, Rubinow DR (2015) Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry 72:714–726CrossRefPubMed
Zurück zum Zitat Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183:414–420CrossRefPubMed Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183:414–420CrossRefPubMed
Zurück zum Zitat Sheehan DV (2002) The management of panic disorder. J Clin Psychiatry 63(suppl 14):17–21PubMed Sheehan DV (2002) The management of panic disorder. J Clin Psychiatry 63(suppl 14):17–21PubMed
Zurück zum Zitat Sheehan KH, Sheehan DV (2008) Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol 23:70–83CrossRefPubMed Sheehan KH, Sheehan DV (2008) Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol 23:70–83CrossRefPubMed
Zurück zum Zitat Sherbourne CD, Wells KB, Hays RD, Rogers W, Burnam MA, Judd LL (1994) Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health specialty outpatients. Am J Psychiatry 151:1777–1784CrossRefPubMed Sherbourne CD, Wells KB, Hays RD, Rogers W, Burnam MA, Judd LL (1994) Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health specialty outpatients. Am J Psychiatry 151:1777–1784CrossRefPubMed
Zurück zum Zitat Silverstein B (2002) Gender differences in the prevalence of somatic versus pure depression: a replication. Am J Psychiatry 159:1051–1052CrossRefPubMed Silverstein B (2002) Gender differences in the prevalence of somatic versus pure depression: a replication. Am J Psychiatry 159:1051–1052CrossRefPubMed
Zurück zum Zitat Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J (1999) An international study of the relation between somatic symptoms and depression. N Engl J Med 341:1329–1335CrossRefPubMed Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J (1999) An international study of the relation between somatic symptoms and depression. N Engl J Med 341:1329–1335CrossRefPubMed
Zurück zum Zitat Soares CN, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58:529–534CrossRefPubMed Soares CN, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58:529–534CrossRefPubMed
Zurück zum Zitat Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N (2001) Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76:874–878CrossRefPubMed Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N (2001) Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76:874–878CrossRefPubMed
Zurück zum Zitat Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JBW, deGruy FVIII, Brody D, Davies M (1995) Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 study. J A M A 274:1511–1517CrossRefPubMed Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JBW, deGruy FVIII, Brody D, Davies M (1995) Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 study. J A M A 274:1511–1517CrossRefPubMed
Zurück zum Zitat Spitzer RL, Kroenke K, Williams JBW (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. J A M A 282:1737–1744CrossRefPubMed Spitzer RL, Kroenke K, Williams JBW (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. J A M A 282:1737–1744CrossRefPubMed
Zurück zum Zitat Spitzer RL, Williams JBW, Kroenke K, Hornyak R, McMurray J (2000) Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD patient health questionnaire obstetrics-gynecology study. Am J Obstet Gynecol 183:759–769CrossRefPubMed Spitzer RL, Williams JBW, Kroenke K, Hornyak R, McMurray J (2000) Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD patient health questionnaire obstetrics-gynecology study. Am J Obstet Gynecol 183:759–769CrossRefPubMed
Zurück zum Zitat Stanaway FF, Kendig HL, Blyth FM, Cumming RG, Naganathan V, Waite LM (2011) Subjective social support in older male Italian-born immigrants in Australia. J Cross Cult Gerontol 26:205–220CrossRefPubMed Stanaway FF, Kendig HL, Blyth FM, Cumming RG, Naganathan V, Waite LM (2011) Subjective social support in older male Italian-born immigrants in Australia. J Cross Cult Gerontol 26:205–220CrossRefPubMed
Zurück zum Zitat Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes DF (2002) Hot flushes. Lancet 360:1851–1861CrossRefPubMed Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes DF (2002) Hot flushes. Lancet 360:1851–1861CrossRefPubMed
Zurück zum Zitat Steinberg EM, Rubinow DR, Bartko JJ, Fortinsky PM, Haq N, Thompson K, Schmidt PJ (2008) A cross sectional evaluation of perimenopausal depression. J Clin Psychiatry 69:973–980CrossRefPubMedPubMedCentral Steinberg EM, Rubinow DR, Bartko JJ, Fortinsky PM, Haq N, Thompson K, Schmidt PJ (2008) A cross sectional evaluation of perimenopausal depression. J Clin Psychiatry 69:973–980CrossRefPubMedPubMedCentral
Zurück zum Zitat Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ (2015) Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100:3975–4011CrossRefPubMed Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ (2015) Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100:3975–4011CrossRefPubMed
Zurück zum Zitat Swan A, Watson HJ, Nathan PR (2009) Quality of life in depression: an important outcome measure in an outpatient cognitive-behavioural therapy group programme? Clin Psychol Psychother 16:485–496CrossRefPubMed Swan A, Watson HJ, Nathan PR (2009) Quality of life in depression: an important outcome measure in an outpatient cognitive-behavioural therapy group programme? Clin Psychol Psychother 16:485–496CrossRefPubMed
Zurück zum Zitat Utian WH (2005) Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 47:1–10 Utian WH (2005) Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 47:1–10
Zurück zum Zitat Weissman A (1976) The discriminability of aspirin in arthritic and non arthritic rats. Pharmacol Biochem Behav 5:583–586CrossRefPubMed Weissman A (1976) The discriminability of aspirin in arthritic and non arthritic rats. Pharmacol Biochem Behav 5:583–586CrossRefPubMed
Zurück zum Zitat Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK (1978) Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 166:317–326CrossRefPubMed Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK (1978) Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 166:317–326CrossRefPubMed
Zurück zum Zitat Wyrwich K, Harnam N, Revicki DA, Locklear JC, Svedsater H, Endicott J (2009) Assessing health-related quality of life in generalized anxiety disorder using the Quality of Life Enjoyment and Satisfaction questionnaire. Int Clin Psychopharmacol 24:289–295CrossRefPubMed Wyrwich K, Harnam N, Revicki DA, Locklear JC, Svedsater H, Endicott J (2009) Assessing health-related quality of life in generalized anxiety disorder using the Quality of Life Enjoyment and Satisfaction questionnaire. Int Clin Psychopharmacol 24:289–295CrossRefPubMed
Zurück zum Zitat Zollner YF, Acquadro C, Schaefer M (2005) Literature review of instruments to assess health-related quality of life during and after menopause. Qual Life Res 14:309–327CrossRefPubMed Zollner YF, Acquadro C, Schaefer M (2005) Literature review of instruments to assess health-related quality of life during and after menopause. Qual Life Res 14:309–327CrossRefPubMed
Metadaten
Titel
Depression during the menopause transition: impact on quality of life, social adjustment, and disability
verfasst von
Bathsheba A. Wariso
Gioia M. Guerrieri
Karla Thompson
Deloris E. Koziol
Nazli Haq
Pedro E. Martinez
David R. Rubinow
Peter J. Schmidt
Publikationsdatum
21.12.2016
Verlag
Springer Vienna
Erschienen in
Archives of Women's Mental Health / Ausgabe 2/2017
Print ISSN: 1434-1816
Elektronische ISSN: 1435-1102
DOI
https://doi.org/10.1007/s00737-016-0701-x

Weitere Artikel der Ausgabe 2/2017

Archives of Women's Mental Health 2/2017 Zur Ausgabe